Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jarl Underhaug

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 8, 2019
A Pharmacological Chaperone Therapy for Acute Intermittent PorphyriaHelene J Bustad, Karen Toska, Caroline Schmitt, et al.
Plos One|November 29, 2012
The peripheral binding of 14-3-3γ to membranes involves isoform-specific histidine residuesHelene J Bustad, Lars Skjaerven, Ming Ying, et al.
Journal of Medicinal Chemistry|October 13, 2015
Discovery of a Specific Inhibitor of Pyomelanin Synthesis in Legionella pneumophilaOscar Aubi, Marte I Flydal, Huaixin Zheng, et al.
Biochemistry|August 26, 2015
Early Events in the Amyloid Formation of the A546T Mutant of Transforming Growth Factor β-Induced Protein in Corneal Dystrophies Compared to the Nonfibrillating R555W and R555Q MutantsHeidi Koldsø, Ole Juul Andersen, Camilla Lund Nikolajsen, et al.
Scientific Reports|October 26, 2017
Conformational stabilization as a strategy to prevent nucleophosmin mislocalization in leukemiaMaría A Urbaneja, Lars Skjærven, Oscar Aubi, et al.
Biochimica Et Biophysica Acta|September 14, 2017
Erratum to "Discovery of compounds that protect tyrosine hydroxylase activity through different mechanisms" [Biochim. Biophys. Acta 1854/9 (2015) 1078-1089]Magnus Hole, Jarl Underhaug, Hector Diez, et al.
Biochimica Et Biophysica Acta|May 12, 2015
Discovery of compounds that protect tyrosine hydroxylase activity through different mechanismsMagnus Hole, Jarl Underhaug, Hector Diez, et al.
Biochimica Et Biophysica Acta|October 17, 2013
Mutation in transforming growth factor beta induced protein associated with granular corneal dystrophy type 1 reduces the proteolytic susceptibility through local structural stabilizationJarl Underhaug, Heidi Koldsø, Kasper Runager, et al.
Molecules (Basel, Switzerland)|March 13, 2024
Biological Evaluations, NMR Analyses, Molecular Modeling Studies, and Overview of the Synthesis of the Marine Natural Product (-)-MucosinJens M J Nolsøe, Jarl Underhaug, Åshild Moi Sørskar, et al.
Cancer Communications (London, England)|January 28, 2023
Impact of small molecule-mediated inhibition of ammonia detoxification on lung malignancies and liver metabolismGeorgios Makris, Semih Kayhan, Marvin Kreuzer, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 8, 2019
A Pharmacological Chaperone Therapy for Acute Intermittent PorphyriaHelene J Bustad, Karen Toska, Caroline Schmitt, et al.
Plos One|November 29, 2012
The peripheral binding of 14-3-3γ to membranes involves isoform-specific histidine residuesHelene J Bustad, Lars Skjaerven, Ming Ying, et al.
Journal of Medicinal Chemistry|October 13, 2015
Discovery of a Specific Inhibitor of Pyomelanin Synthesis in Legionella pneumophilaOscar Aubi, Marte I Flydal, Huaixin Zheng, et al.
Biochemistry|August 26, 2015
Early Events in the Amyloid Formation of the A546T Mutant of Transforming Growth Factor β-Induced Protein in Corneal Dystrophies Compared to the Nonfibrillating R555W and R555Q MutantsHeidi Koldsø, Ole Juul Andersen, Camilla Lund Nikolajsen, et al.
Scientific Reports|October 26, 2017
Conformational stabilization as a strategy to prevent nucleophosmin mislocalization in leukemiaMaría A Urbaneja, Lars Skjærven, Oscar Aubi, et al.
Biochimica Et Biophysica Acta|September 14, 2017
Erratum to "Discovery of compounds that protect tyrosine hydroxylase activity through different mechanisms" [Biochim. Biophys. Acta 1854/9 (2015) 1078-1089]Magnus Hole, Jarl Underhaug, Hector Diez, et al.
Biochimica Et Biophysica Acta|May 12, 2015
Discovery of compounds that protect tyrosine hydroxylase activity through different mechanismsMagnus Hole, Jarl Underhaug, Hector Diez, et al.
Biochimica Et Biophysica Acta|October 17, 2013
Mutation in transforming growth factor beta induced protein associated with granular corneal dystrophy type 1 reduces the proteolytic susceptibility through local structural stabilizationJarl Underhaug, Heidi Koldsø, Kasper Runager, et al.
Molecules (Basel, Switzerland)|March 13, 2024
Biological Evaluations, NMR Analyses, Molecular Modeling Studies, and Overview of the Synthesis of the Marine Natural Product (-)-MucosinJens M J Nolsøe, Jarl Underhaug, Åshild Moi Sørskar, et al.
Cancer Communications (London, England)|January 28, 2023
Impact of small molecule-mediated inhibition of ammonia detoxification on lung malignancies and liver metabolismGeorgios Makris, Semih Kayhan, Marvin Kreuzer, et al.
Pageof 5